Datar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services.
FDA Grants Breakthrough Designation for Datar Cancer Genetics Early-Stage Prostate Cancer Detection Blood Test
Virtus Group announces partnership with Datar Cancer Genetics for personalized precision oncology solutions in Kuwait
US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics
UK – National Institute for Health and Care Excellence (NICE) Issues MedTech Innovation Briefing on ‘Trublood®- Prostate’ for Precision Non-invasive Prostate Cancer Diagnosis Described by Experts as a ‘Game Changer’
US FDA Grants Breakthrough Designation for Trucheck-Breast, a Blood Test to Detect Early-Stage Breast Cancer.